ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 266,044 | 237,462 | 247,060 | 227,813 | 211,371 |
| Cost of Goods | 100,158 | 93,582 | 100,269 | 93,389 | 74,615 |
| Gross Profit | 165,886 | 143,880 | 146,791 | 134,424 | 136,756 |
| Operating Expenses | 125,584 | 105,574 | 112,293 | 98,573 | 123,479 |
| Operating Income | 40,460 | 38,888 | 34,767 | 36,240 | 13,892 |
| Interest Expense | 3,636 | 3,769 | 4,411 | 4,727 | 5,438 |
| Other Income | 273 | 5,102 | 1,123 | 2,287 | 2,071 |
| Pre-tax Income | 37,097 | 40,221 | 31,479 | 33,800 | 10,525 |
| Income Tax | 12,386 | 10,729 | 3,989 | 7,183 | 1,976 |
| Net Income Continuous | 24,711 | 29,492 | 27,490 | 26,617 | 8,549 |
| Net Income | $24,711 | $29,492 | $27,490 | $26,617 | $8,549 |
| EPS Basic Total Ops | 1.09 | 1.31 | 1.24 | 1.19 | 0.37 |
| EPS Basic Continuous Ops | 1.17 | 1.41 | 1.35 | 1.33 | 0.43 |
| EPS Diluted Total Ops | 1.05 | 1.28 | 1.14 | 1.13 | 0.36 |
| EPS Diluted Continuous Ops | 1.13 | 1.37 | 1.23 | 1.26 | 0.42 |
| EPS Diluted Before Non-Recurring Items | 1.82 | 1.68 | 1.98 | 1.64 | 1.38 |
| EBITDA(a) | $60,100 | $59,807 | $57,380 | $58,872 | $37,173 |